[{"address1": "535 W 24th Street", "address2": "5th Floor", "city": "New York", "state": "NY", "zip": "10011", "country": "United States", "phone": "855 508 3568", "website": "https://www.neurogene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rachel L. McMinn Ph.D.", "age": 52, "title": "Founder, Executive Chair & CEO", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 929410, "exercisedValue": 0, "unexercisedValue": 249075}, {"maxAge": 1, "name": "Ms. Christine Mikail Cvijic J.D.", "age": 47, "title": "President & CFO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 746750, "exercisedValue": 0, "unexercisedValue": 1035052}, {"maxAge": 1, "name": "Dr. Julie  Jordan M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 651036, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.89, "open": 18.54, "dayLow": 17.47, "dayHigh": 18.58, "regularMarketPreviousClose": 18.89, "regularMarketOpen": 18.54, "regularMarketDayLow": 17.47, "regularMarketDayHigh": 18.58, "payoutRatio": 0.0, "beta": 2.026, "forwardPE": -3.8558953, "volume": 143738, "regularMarketVolume": 143738, "averageVolume": 199662, "averageVolume10days": 114160, "averageDailyVolume10Day": 114160, "bid": 17.41, "ask": 17.75, "bidSize": 1, "askSize": 1, "marketCap": 273549856, "fiftyTwoWeekLow": 6.875, "fiftyTwoWeekHigh": 37.266, "allTimeHigh": 1115.0, "allTimeLow": 6.875, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 19.6484, "twoHundredDayAverage": 20.634125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 18347868, "profitMargins": 0.0, "floatShares": 5210149, "sharesOutstanding": 15489800, "sharesShort": 3536210, "sharesShortPriorMonth": 3538773, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.2283, "heldPercentInsiders": 0.085439995, "heldPercentInstitutions": 1.0555999, "shortRatio": 19.26, "shortPercentOfFloat": 0.28370002, "impliedSharesOutstanding": 15489800, "bookValue": 17.972, "priceToBook": 0.9826397, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -85130000, "trailingEps": -4.1, "forwardEps": -4.58, "lastSplitFactor": "1:4", "lastSplitDate": 1702944000, "enterpriseToEbitda": -0.195, "52WeekChange": 0.048693538, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 17.66, "targetHighPrice": 70.0, "targetLowPrice": 46.0, "targetMeanPrice": 57.2, "targetMedianPrice": 50.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 265410000, "totalCashPerShare": 17.135, "ebitda": -94208000, "totalDebt": 10208000, "quickRatio": 18.101, "currentRatio": 18.39, "totalRevenue": 0, "debtToEquity": 3.844, "revenuePerShare": 0.0, "returnOnAssets": -0.26914, "returnOnEquity": -0.42253, "grossProfits": -69719000, "freeCashflow": -47322124, "operatingCashflow": -77240000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NGNE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 1.9818821, "postMarketPrice": 18.01, "postMarketChange": 0.35000038, "regularMarketChange": -1.2299995, "regularMarketDayRange": "17.47 - 18.58", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 199662, "fiftyTwoWeekLowChange": 10.785, "fiftyTwoWeekLowChangePercent": 1.5687273, "fiftyTwoWeekRange": "6.875 - 37.266", "fiftyTwoWeekHighChange": -19.605999, "fiftyTwoWeekHighChangePercent": -0.5261096, "fiftyTwoWeekChangePercent": 4.869354, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394202600000, "marketState": "CLOSED", "earningsTimestampStart": 1763154000, "earningsTimestampEnd": 1763154000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.1, "epsForward": -4.58, "epsCurrentYear": -4.19, "priceEpsCurrentYear": -4.214797, "fiftyDayAverageChange": -1.9883995, "shortName": "Neurogene Inc.", "longName": "Neurogene Inc.", "corporateActions": [], "postMarketTime": 1769818244, "regularMarketTime": 1769806801, "exchange": "NGM", "messageBoardId": "finmb_602062523", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.5113797, "regularMarketPrice": 17.66, "fiftyDayAverageChangePercent": -0.10119906, "twoHundredDayAverageChange": -2.974125, "twoHundredDayAverageChangePercent": -0.14413624, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "displayName": "Neurogene", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]